Search

everythinglearnresearchcommunity

for

Search:↓

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

The formulated gel is a promising treatment for alopecia areata.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Certain miRNAs may play a role in sheep hair follicle development, which could help improve wool production.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

The hair follicle dermal sheath is essential for hair shedding and needs to communicate with the outer root sheath for normal hair growth cycles.

The model and estimator can predict drug exposure in kidney transplant patients well.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

IL-24 contributes to skin aging by increasing collagen-degrading enzymes and decreasing collagen production when exposed to air pollution.

Ruxolitinib can cause a delayed skin reaction on the nose.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

After skin is damaged, noncoding dsRNA helps prostaglandins and Wnts work together to repair tissue and promote hair growth.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.